Maruyama Kenji, Uchiyama Shinichiro, Shiga Tsuyoshi, Iijima Mutsumi, Ishizuka Kentaro, Hoshino Takao, Kitagawa Kazuo
Department of Neurology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Clinical Research Center, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan.
Cerebrovasc Dis Extra. 2017;7(1):35-43. doi: 10.1159/000457808. Epub 2017 Mar 2.
Since stroke patients with nonvalvular atrial fibrillation (NVAF) have poor outcomes in general, the prediction of outcomes following discharge is of utmost concern for these patients. We previously reported that brain natriuretic peptide (BNP) levels were significantly higher in NVAF patients with larger infarcts, higher modified Rankin Scale (mRS) score, and higher CHADS2 score. In the present study, we evaluated an array of variables, including BNP, in order to determine significant predictors for functional outcome in patients with NVAF after acute ischemic stroke (AIS).
A total of 615 consecutive patients with AIS within 48 h of symptom onset, admitted to our hospital between April 2010 and October 2015, were retrospectively searched. Among these patients, we enrolled consecutive patients with NVAF. We evaluated the mRS score 3 months after onset of stroke and investigated associations between mRS score and the following clinical and echocardiographic variables. Categorical variables included male sex, current smoking, alcohol intake, hypertension, diabetes mellitus, dyslipidemia, coronary artery disease, peripheral artery disease, use of antiplatelet drugs, anticoagulants, or tissue plasminogen activator (tPA), and infarct size. Continuous variables included age, systolic blood pressure (SBP), diastolic blood pressure, hemoglobin, creatinine, D-dimer, brain natriuretic peptide (BNP), left atrial diameter, left ventricular ejection fraction (EF), and early mitral inflow velocity/diastolic mitral annular velocity (E/e'). We also analyzed the association of prestroke CHADS2, CHA2DS2-VASc, and R2CHADS2 scores, and National Institutes of Health Stroke Scale (NIHSS) score on admission with mRS score 3 months after the onset of stroke. Patients were classified into 2 groups according to mRS score: an mRS score ≤2 was defined as good outcome, an mRS score ≥3 was defined as poor outcome. To clarify the correlations between categorical or continuous variables and mRS score, uni- and multivariate logistic regression models using the stepwise variable selection method were applied.
Among 157 patients with NVAF after AIS, 63.7% were male and the mean age was 75.9 years. In univariate regression analysis, poor outcome (mRS score ≥3) was associated with use of tPA, infarct size, age, SBP, BNP, EF, and NIHSS score. In multivariate regression analysis, BNP levels (odds ratio [OR] 6.40; 95% confidence interval [CI] 1.26-32.43; p = 0.0235) and NIHSS score (OR 2.87; 95% CI 1.84-4.47; p < 0.001) were significantly associated with poor outcome (mRS score ≥3) after adjusting for use of tPA, infarct size, age, BNP, EF, and NIHSS score.
CONCLUSIONS: Apart from NIHSS score, BNP was a very useful predictor for long-term outcomes of patients with NVAF after AIS. .
由于非瓣膜性心房颤动(NVAF)的中风患者总体预后较差,出院后预后的预测是这些患者最为关注的问题。我们之前报道过,梗死面积较大、改良Rankin量表(mRS)评分较高以及CHADS2评分较高的NVAF患者,其脑钠肽(BNP)水平显著更高。在本研究中,我们评估了一系列变量,包括BNP,以确定急性缺血性中风(AIS)后NVAF患者功能预后的重要预测因素。
回顾性检索了2010年4月至2015年10月期间我院收治的615例症状发作后48小时内连续入院的AIS患者。在这些患者中,我们纳入了连续的NVAF患者。我们评估了中风发作3个月后的mRS评分,并研究了mRS评分与以下临床和超声心动图变量之间的关联。分类变量包括男性、当前吸烟、饮酒、高血压、糖尿病、血脂异常、冠状动脉疾病、外周动脉疾病、使用抗血小板药物、抗凝剂或组织纤溶酶原激活剂(tPA)以及梗死面积。连续变量包括年龄、收缩压(SBP)、舒张压、血红蛋白、肌酐、D-二聚体、脑钠肽(BNP)、左心房直径、左心室射血分数(EF)以及早期二尖瓣流入速度/二尖瓣环舒张期速度(E/e')。我们还分析了中风前CHADS2、CHA2DS2-VASc和R2CHADS2评分以及入院时美国国立卫生研究院卒中量表(NIHSS)评分与中风发作3个月后mRS评分的关联。根据mRS评分将患者分为两组:mRS评分≤2定义为良好预后,mRS评分≥3定义为不良预后。为了阐明分类或连续变量与mRS评分之间的相关性,应用了使用逐步变量选择方法的单因素和多因素逻辑回归模型。
在157例AIS后NVAF患者中,63.7%为男性,平均年龄为75.9岁。在单因素回归分析中,不良预后(mRS评分≥3)与使用tPA、梗死面积、年龄、SBP、BNP、EF和NIHSS评分相关。在多因素回归分析中,在调整了使用tPA、梗死面积、年龄、BNP、EF和NIHSS评分后,BNP水平(比值比[OR] 6.40;95%置信区间[CI] 1.26 - 32.43;p = 0.0235)和NIHSS评分(OR 2.87;95% CI 1.84 - 4.47;p < 0.001)与不良预后(mRS评分≥3)显著相关。
除NIHSS评分外,BNP是AIS后NVAF患者长期预后的一个非常有用的预测指标。